Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis

Stopped early · Not applicable

Conditions studied: Idiopathic Pulmonary Fibrosis

In brief

Idiopathic pulmonary fibrosis (IPF), a chronic fibrotic lung disease of unknown cause, is characterized by relentless progression, with a three-year mortality of up to 50%. IPF has high morbidity, with 90% of patients reporting dyspnea at the time of diagnosis and this is strongly correlated with quality of life and mortality. As IPF progress, breathlessness worsens, physical functional capacity declines, and health-related quality of life deteriorates. Pulmonary rehabilitation (PR) can improve well-being in patients with other chronic lung disease, but little is known regarding PR in IPF.

Key facts

Study ID

NCT03480451

Run by

Medical College of Wisconsin

People needed

1

Starts

2017-09-12

Expected to finish

2019-02-01

Last updated by the study team

2019-07-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of IPF confirmed by lung biopsy or by characteristic pattern on high resolution computed tomogram (HRCT)
• No identifiable cause of lung fibrosis
• PR not received in the past year
• Ability to walk

You may not qualify if…

• History of unstable angina
• Deterioration cardiac or neurological disease
• Pregnancy or lactation
• Degenerative arthritis or other limitation to mobility
• PR in the past 12 months

Where it is running

• Froedtert Memorial Lutheran Hospital — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.